Zu X - Search Results

1

Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.

Shen Y, Zhong J, Liu J, Liu K, Zhao J, Xu T, Zeng T, Li Z, Chen Y, Ding W, Wen G, Zu X, Cao R. Shen Y, et al. Among authors: zu x. Oncol Rep. 2018 Jun;39(6):2604-2612. doi: 10.3892/or.2018.6350. Epub 2018 Apr 2. Oncol Rep. 2018. PMID: 29620287 Free PMC article.

2

Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.

Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y. Liu F, et al. Among authors: zu x. Oncol Rep. 2010 May;23(5):1469-75. doi: 10.3892/or_00000786. Oncol Rep. 2010. PMID: 20372866

3

Effect of human S100A13 gene silencing on FGF-1 transportation in human endothelial cells.

Cao R, Yan B, Yang H, Zu X, Wen G, Zhong J. Cao R, et al. Among authors: zu x. J Formos Med Assoc. 2010 Sep;109(9):632-40. doi: 10.1016/S0929-6646(10)60103-9. J Formos Med Assoc. 2010. PMID: 20863990 Free article.

4

Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.

Zhong J, Cao RX, Hong T, Yang J, Zu XY, Xiao XH, Liu JH, Wen GB. Zhong J, et al. Gene. 2011 Nov 1;487(1):1-9. doi: 10.1016/j.gene.2011.06.022. Epub 2011 Jul 18. Gene. 2011. PMID: 21820040

5

Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.

Zu X, Zhang Q, Cao R, Liu J, Zhong J, Wen G, Cao D. Zu X, et al. Cell Tissue Res. 2012 Jan;347(1):73-84. doi: 10.1007/s00441-011-1225-3. Epub 2011 Aug 16. Cell Tissue Res. 2012. PMID: 21845401 Review.

6

miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.

Yang X, Yin J, Yu J, Xiang Q, Liu Y, Tang S, Liao D, Zhu B, Zu X, Tang H, Lei X. Yang X, et al. Among authors: zu x. Oncol Rep. 2012 Jan;27(1):250-7. doi: 10.3892/or.2011.1472. Epub 2011 Sep 22. Oncol Rep. 2012. PMID: 21947305

7

Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.

Zhong J, Cao RX, Zu XY, Hong T, Yang J, Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH, Wen GB. Zhong J, et al. FEBS J. 2012 Jan;279(2):316-35. doi: 10.1111/j.1742-4658.2011.08426.x. Epub 2011 Dec 9. FEBS J. 2012. PMID: 22093364 Free article.

8

ATP citrate lyase inhibitors as novel cancer therapeutic agents.

Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH, Quan ZH, Pizzorno G. Zu XY, et al. Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):154-67. doi: 10.2174/157489212799972954. Recent Pat Anticancer Drug Discov. 2012. PMID: 22339355 Review.

9

An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells.

Zhang QH, Zu XY, Cao RX, Liu JH, Mo ZC, Zeng Y, Li YB, Xiong SL, Liu X, Liao DF, Yi GH. Zhang QH, et al. Among authors: zu xy. Biochem Biophys Res Commun. 2012 Mar 30;420(1):17-23. doi: 10.1016/j.bbrc.2012.02.103. Epub 2012 Feb 27. Biochem Biophys Res Commun. 2012. PMID: 22390933

10

Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation.

Yang X, Zu X, Tang J, Xiong W, Zhang Y, Liu F, Jiang Y. Yang X, et al. Among authors: zu x. Mol Med Rep. 2012 Jun;5(6):1475-80. doi: 10.3892/mmr.2012.846. Epub 2012 Mar 23. Mol Med Rep. 2012. PMID: 22447046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters